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DYSREGULATED CIRCADIAN RHYTHM PATHWAY IN HUMAN
OSTEOARTHRITIS: NR1D1 AND BMAL1 SUPPRESSION ALTERS TGF-В
AND IL-1В SIGNALING IN CHONDROCYTES
R. Akagi y, K.M. Fisch y, O. Alvarez-Garcia y, T. Teramura y,
Y. Muramatsu y, M. Saito z, T. Sasho x, A.I. Su y, M.K. Lotz y. y The Scripps
Res. Inst., La Jolla, CA, USA; z Toho Univ. Sakura Med. Ctr., Sakura, Japan;
xChiba Univ., Chiba, Japan
Purpose: Circadian rhythm (CR) was identiﬁed by RNA sequencing as
the most dysregulated pathway in human osteoarthritis (OA) knee
articular cartilage. This study examined circadian rhythmicity in cul-
tured chondrocytes and the role of the CR genes NR1D1 and BMAL1 in
regulating chondrocyte functions. NR1D1 is a negative regulator of
BMAL1, a core clock gene that regulates circadian rhythmicity.
Methods: RNA was extracted from human cartilage tissues harvested
from normal and OA knees (n¼14 each), and expression levels of NR1D1
and BMAL1 mRNA were assessed by quantitative PCR. NR1D1 protein
expressionwas conﬁrmed by immunohistochemistry in normal and OA
human cartilage, as well as in normal knees and knees with surgically
induced OA of mice. To examine the circadian rhythmicity of gene
expression in cultured chondrocytes isolated from normal human car-
tilage, chondrocytes were synchronized by dexamethasone and har-
vested at 4-hour intervals up to 48 hours for RNA and protein
extraction. Chondrocytes were then treated with small interfering RNA
(siRNA) for NR1D1 or BMAL1, followed by IL-1b or TGFb stimulation to
test the effect of knock down on response to IL-1b and TGFb.
Results: Both NR1D1 and BMAL1 mRNA levels were signiﬁcantly
reduced in OA cartilage, compared to normal cartilage. NR1D1 protein
was predominantly expressed in the superﬁcial and upper-mid zone of
normal cartilage, both in human and in mouse knees. The protein
expression was reduced in OA cartilage, although high expression was
observed in cluster cells. In surgically inducedOA inmice,NR1D1protein
expression was signiﬁcantly reduced before cartilage damage occurred.
In cultured human chondrocytes, a clear circadian rhythmicity was
observed for NR1D1 and BMAL1 mRNA levels. NR1D1 expressionwas at
its lowest level at T12 and T36, whereas highest expression was
observed at T24 and T48. The expression pattern of BMAL1 displayed
the reversed pattern. Treatment with siRNA signiﬁcantly suppressed
levels of both genes at all time points, but the rhythmic expression
pattern was preserved for NR1D1. Increased BMAL1 expression was
observed at T24 and T48 after knocking down NR1D1, and decreased
NR1D1 levels were observed at all time points after knocking down
BMAL1. IL-1b treatment signiﬁcantly induced IL6, COX2, iNOS, MMP13
and ADAMTS4. NR1D1 knock down further increased the expression
levels of iNOS, MMP13 and ADAMTS4, while by contrast the IL-1
induction of IL6 and COX2 was blunted. Genome-wide sequencing of
RNA from chondrocytes treated with NR1D1 and BMAL1 siRNA iden-
tiﬁed 330 and 68 genes, respectively, that were signiﬁcantly different.
TGFb signaling pathway was affected by both siRNAs. NR1D1 and
BMAL1 knock down increased the expression of elastin and tenascin C,
following induction by TGFb.
Conclusions: The circadian rhythm pathway is dysregulated in OA
cartilage. Interference with circadian rhythmicity in cultured chon-
drocytes affects IL-1b and TGF-b signaling, which are central pathways
in cartilage homeostasis and OA pathogenesis.
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DIO2-KNOCKOUT MODULATES CIRCADIAN CLOCK GENES IN
ARTICULAR CARTILAGE THROUGH THYROID HORMONE SIGNALING
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Purpose: Previously, the type II deiodinase (D2) gene (DIO2) has been
identiﬁed as relevant OA susceptibility gene. D2 regulates the bio-
availability of intracellular triiodothyronine (T3) and expression of DIO2
mRNA and D2 protein levels in osteoarthritic cartilage are increased as
compared to healthy cartilage. Given the function of T3 signalling this
should be considered detrimetnal to cartilage integrity. In this respect,
we showed that knocking-out Dio2 expression in C57Bl/6 mice, has aprotective effect particularly after administrating a stringent running
regime. Here, we aim to identify intrinsic underlying differences in
articular cartilage tissue homeostasis between wild-type- and Dio2-
knockout-mice.
Methods: Genome wide gene expression data (Illumina MouseWG-6
v2) of knee-cartilage of wild-type and C57Bl/6-Dio2 -/- -mice was used
to detect the involved gene expression pathways. To increase power in
our analysis, probes with a jfold-changej  1.5 between wild-type- and
knockout-mice were analyzed and subsequent multiple test correction
according the “bonferroni-method” was performed. STRING-db and
STITCH analysis was applied to visualize protein-protein (PPI) and
protein-chemical interaction (PCI)-networks.
Results: Comparing the microarray-data of articular cartilage of knock-
out- and wild-type-mice showed 69 probes that were differentially
expressed with a jfold-changej  1.5 whereas 4 probes, representing 4
genes remained signiﬁcant after subsequent multiple testing correction.
Notably, two of these genes are known canonical genes, involved in the
circadian clock rhythm. Except for Calr (FC ¼ -1.73; Padj. ¼ 0.00050),
direct protein interaction (PPI) was found between LOC100047427 (Pre-
dicted: similar to thyroid hormone receptor (Thra); FC ¼ 1.74; Padj. ¼
0.0331) and circadian clock genes, Dbp (FC ¼ 2.61; Padj. ¼ 0.0264) and
Nr1d1 (FC ¼ 1.57; Padj. ¼ 0.0307) (Figure 1A). To visualize the inter-
relationship of this PPIwith respectivelyDio2, T3 and its receptor Thra,we
next added these in a STITCH-db analysis (Figure 1B) and conﬁrmed
interaction of this PPI with thyroid signaling. Furthermore, ChAP-seq
experiments performed by Chatonnet et al; (2013) showed that the
promoters of these genes are under inﬂuence of the thyroid hormone
receptor (THR)-alpha (Dbp) and -beta (Nr1d1) in mice.
Conclusions: We demonstrated that Dio2:-depletion in articular carti-
lage results in signiﬁcanthigherexpressionof circadianclock genesNr1d1
andDbp, likelymediatedvia the thyroidhormone receptors. Furthermore,
our data demonstrates that upregulation of circadian rhythmgenes could,
in part, explain the previously established beneﬁcial effect of articular
cartilage tissue homeostasis of Dio2 knockout mice.
Figure 1. Gene networks in search tool for the retrieval of interacting
genes. (A) Screenshot of the PPI-network for the 4 genes signiﬁcantly
differing >j1.5j-fold between knockout- and wild-type-mice (STRING-db).
(B) Screenshot of the PCI-network for the 4 genes signiﬁcantly differing
>j1.5j-fold between knockout- and wild-type-mice, including Dio2 and
triiodothyronine (T3) (STITCH).
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INCIDENT BISPHOSPHONATE USE AND RISK OF KNEE REPLACEMENT
SURGERY AMONG WOMEN WITH INCIDENT KNEE OSTEOARTHRITIS
T. Neogi, C. Peloquin, Y. Zhang, D. Misra. Boston Univ. Sch. of Med.,
Boston, MA, USA
Purpose: Bone remodeling as a therapeutic target in knee osteoarthritis
(OA) has gainedmuch interest, but the effects of antiresorptive agents on
knee OA have been conﬂicting. Since mechanical factors play a central
role in knee OA and bone adapts readily to mechanical stresses, it is
important to understand the effects of modulating bone remodeling via
antiresorptive agents such as bisphosphonates on the course of knee OA.
We assessed the relation of incident bisphosphonate use to the risk of
knee replacement (KR) surgery among women with incident knee OA.
Methods: We used data from The Health Improvement Network
(THIN), a general practitioner (GP) electronic medical records database
representative of the UK general population. We included women aged
50-89 with incident knee OA between 1/1/2003-12/31/2012 who had
1 GP visit or 1 prescription during the one year prior to the knee OA
diagnosis. We excluded womenwith existing KR (prior to incident knee
OA or bisphosphonate use), those less likely to be KR candidates
(BMI>40, history of joint infection, high risk cancers (pancreatic,
esophageal, gastric or other metastatic), dialysis, supplemental oxygen,
